Plain-English translation of NCT05180942 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Melanoma research guide →This study is tracking how checkpoint inhibitor immunotherapy drugs affect the heart arteries of melanoma patients. Researchers will use heart imaging scans to monitor whether artery plaque builds up in people receiving this melanoma treatment, and to understand the natural course of heart artery changes in these patients.
Immunotherapy drugs have transformed melanoma treatment, but researchers want to understand whether this medication affects heart artery health over time — information that could help doctors better protect patients receiving these life-saving cancer treatments.
You likely qualify if…
You likely don't qualify if…
You will undergo heart imaging scans (CTCA scans) at the start of the study and at follow-up visits while you receive your melanoma treatment. These scans allow researchers to see if plaque is building up in your heart arteries and track any changes over time. The study takes place at multiple sites across Australia, and you'll need to be willing to return for these follow-up appointments.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Australia